Case Series of SMART Syndrome: Expanding the Spectrum of Post-radiation Neurological Complications
Jayant Yadav1, Aarish Dhillon1, Ritu Bagla2, Razaz Mageid2
1Tufts Medical Center, 2Lahey Hospital and Medical Center
Objective:
To describe the clinical presentation, radiological findings, treatment and outcomes in patients diagnosed with stroke-like migraine attacks after radiation therapy (SMART) syndrome, and to highlight the diagnostic challenges and importance of early recognition for appropriate triage and treatment. 
Background:
SMART (Stroke-like Migraine Attacks after Radiation Therapy) syndrome is a rare, delayed complication of cranial irradiation, increasingly recognized in patients treated for intracranial neoplasms.  
Design/Methods:
N/A
Results:

We report three cases of SMART syndrome presenting years to decades after cranial irradiation for various intracranial tumors. The first case involved a 55-year-old man with prior right temporal glioblastoma who developed progressive left-sided visual field loss, neglect, visual hallucinations and seizures. MRI revealed right parietal cortical enhancement, and symptoms resolved with antiepileptics and steroid taper over three weeks. The second case describes a 74-year-old man with a history of head and neck squamous cell carcinoma treated with radiation, who presented with subacute aphasia and confusion. MRI findings and clinical course were consistent with SMART syndrome, with marked improvement following corticosteroid therapy. The third case involved a 74-year-old man with a history of right frontotemporal meningioma treated radiation, presenting with acute left hemiparesis and visual field deficits. MRI and EEG findings supported the diagnosis of SMART syndrome, and the patient improved with antiepileptics and a short course of steroids. 

It often mimics acute stroke or tumor recurrence, leading to diagnostic challenges and potential for unnecessary interventions. MRI is essential for diagnosis revealing characteristics include  unilateral cortical enhancement and edema. While most patients experience symptom resolution, a minority may have persistent deficits. Corticosteroids and antiepileptics are commonly used, but optimal management strategies remain undefined. 

Conclusions:
Increased awareness and recognition of SMART syndrome are crucial to avoid unnecessary interventions, expediting treatment, and improving patient outcomes. 
10.1212/WNL.0000000000213304
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.